Singapore markets closed

Eli Lilly and Company (LLY)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
334.38+23.28 (+7.48%)
At close: 04:03PM EDT
332.47 -1.91 (-0.57%)
Pre-market: 07:28AM EDT
Full screen
Loading interactive chart…
  • Motley Fool

    Why Biogen, Lilly, and Prothena Stocks Are Skyrocketing Today

    Shares of Biogen (NASDAQ: BIIB) were skyrocketing 36% as of 11:10 a.m. ET on Wednesday. The huge gain came after the company and its partner Eisai (OTC: ESALY) announced positive results on Tuesday from their late-stage Clarity AD study evaluating lecanemab in treating Alzheimer's disease. The news also propelled two stocks of other drugmakers developing Alzheimer's disease drugs significantly higher.

  • Zacks

    Biogen's (BIIB) Lecanemab Meets Goal in Alzheimer's Study

    Biogen (BIIB) and Eisai's Clarity AD study showed that treatment with lecanemab in the early stages of Alzheimer's disease reduces the rate of clinical decline on the CDR-SB scale by 27% compared to placebo.

  • Zacks

    AZN vs. LLY: Which Stock Is the Better Value Option?

    AZN vs. LLY: Which Stock Is the Better Value Option?